Literature DB >> 34057145

Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart Study.

Eduardo Marques Zilli1, Adrienne O'Donnell2, Joel Salinas3, Hugo J Aparicio4,5, Mitzi Michelle Gonzales1, Mini Jacob1, Alexa Beiser2,4, Sudha Seshadri1,2,4,5.   

Abstract

BACKGROUND: An association between chronic infectious diseases and development of dementia has been suspected for decades, based on the finding of pathogens in postmortem brain tissue and on serological evidence. However, questions remain regarding confounders, reverse causality, and how accurate, reproducible and generalizable those findings are.
OBJECTIVE: Investigate whether exposure to Herpes simplex (manifested as herpes labialis), Chlamydophila pneumoniae (C. pneumoniae), Helicobacter pylori (H. pylori), and cytomegalovirus (CMV) modifies the risk of dementia in a populational cohort.
METHODS: Questionnaires regarding incidence of herpes infections were administered to Original Framingham Study participants (n = 2,632). Serologies for C. pneumoniae, H. pylori, and CMV were obtained in Original (n = 2,351) and Offspring cohort (n = 3,687) participants. Participants are under continuous dementia surveillance. Brain MRI and neuropsychological batteries were administered to Offspring participants from 1999-2005. The association between each infection and incident dementia was tested with Cox models. Linear models were used to investigate associations between MRI or neuropsychological parameters and serologies.
RESULTS: There was no association between infection serologies and dementia incidence, total brain volume, and white matter hyperintensities. Herpes labialis was associated with reduced 10-year dementia risk (HR 0.66, CI 0.46-0.97), but not for the duration of follow-up. H. pylori antibodies were associated with worse global cognition (β -0.14, CI -0.22, -0.05).
CONCLUSION: We found no association between measures of chronic infection and incident dementia, except for a reduction in 10-year dementia risk for patients with herpes labialis. This unexpected result requires confirmation and further characterization, concerning antiviral treatment effects and capture of episodes.

Entities:  

Keywords:  Alzheimer’s disease; Framingham; dementia; herpes labialis; viral infections

Mesh:

Year:  2021        PMID: 34057145      PMCID: PMC8903174          DOI: 10.3233/JAD-200957

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  57 in total

1.  Recurrent herpes labialis and Herpes simplex virus-1 genitalis: what is the link?

Authors:  Sergio Delmonte; Francesca Sidoti; Simone Ribero; Ivano Dal Conte; Antonio Curtoni; Giulia Ciccarese; Elena Stroppiana; Maria L Stella; Cristina Costa; Rossana Cavallo; Alfredo Rebora; Francesco Drago
Journal:  G Ital Dermatol Venereol       Date:  2017-02-08       Impact factor: 2.011

2.  Reactivated herpes simplex infection increases the risk of Alzheimer's disease.

Authors:  Hugo Lövheim; Jonathan Gilthorpe; Rolf Adolfsson; Lars-Göran Nilsson; Fredrik Elgh
Journal:  Alzheimers Dement       Date:  2014-07-17       Impact factor: 21.566

3.  Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain.

Authors:  R H Ring; J M Lyons
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 4.  The controversial natural history of oral herpes simplex virus type 1 infection.

Authors:  Stefano Petti; Giovanni Lodi
Journal:  Oral Dis       Date:  2019-11-27       Impact factor: 3.511

5.  Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.

Authors:  C Lahoz; E J Schaefer; L A Cupples; P W Wilson; D Levy; D Osgood; S Parpos; J Pedro-Botet; J A Daly; J M Ordovas
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

Review 6.  Human herpes simplex labialis.

Authors:  M Fatahzadeh; R A Schwartz
Journal:  Clin Exp Dermatol       Date:  2007-11       Impact factor: 3.470

7.  Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals.

Authors:  Lisa L Barnes; Ana W Capuano; Alison E Aiello; Arlener D Turner; Robert H Yolken; E Fuller Torrey; David A Bennett
Journal:  J Infect Dis       Date:  2014-08-08       Impact factor: 5.226

Review 8.  Herpes Labialis: An Update.

Authors:  Alexander K C Leung; Benjamin Barankin
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2017

9.  Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage) : Randomized, controlled double-blind study.

Authors:  Jagienka Jautová; Hana Zelenková; Katarína Drotarová; Alena Nejdková; Božena Grünwaldová; Marie Hladiková
Journal:  Wien Med Wochenschr       Date:  2018-11-07

10.  Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden.

Authors:  Karin Lopatko Lindman; Eva-Stina Hemmingsson; Bodil Weidung; Jon Brännström; Maria Josefsson; Jan Olsson; Fredrik Elgh; Peter Nordström; Hugo Lövheim
Journal:  Alzheimers Dement (N Y)       Date:  2021-02-14
View more
  1 in total

Review 1.  Gram-negative bacteria and their lipopolysaccharides in Alzheimer's disease: pathologic roles and therapeutic implications.

Authors:  Hyeon Soo Kim; Sujin Kim; Soo Jung Shin; Yong Ho Park; Yunkwon Nam; Chae Won Kim; Kang Won Lee; Sung-Min Kim; In Duk Jung; Hyun Duk Yang; Yeong-Min Park; Minho Moon
Journal:  Transl Neurodegener       Date:  2021-12-07       Impact factor: 8.014

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.